Bio-Vascular
This article was originally published in The Gray Sheet
Executive Summary
Plans to repurchase up to 200,000 shares of common stock "in the open market from time to time," according to a July 23 press release. The shares would constitute up to 3.6% of the St. Paul, Minnesota cardiac and vascular surgery product maker's approximately 5.6 mil. outstanding shares.